Brian Malik joined the T1D Fund in 2019, coming from Artisan Healthcare Consulting where he worked with pharmaceutical clients to provide early commercial and clinical development strategy for therapeutics across a range of diseases. Prior to Artisan, Brian conducted due diligence on academic technologies at Celdara Medical.
Brian received his Ph.D. in Microbiology and Immunology from Dartmouth College. His thesis research focused on determining how an autoimmune disease supports an anti-tumor immune response. He received his B.S from Bucknell University in Cellular Biology / Biochemistry.